Age Related Memory Impairment - Pipeline Review, H2 2014

1. Age Related Memory Impairment - Pipeline Review, H2 2014 No. Pages : 34 Published on : Dec-2014

2. Report Description ‘Age Related Memory Impairment - Pipeline Review, H2 2014’, provides an overview of the Age Related Memory Impairment’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Age Related Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Memory Impairment and special features on late-stage and discontinued projects. To Get More Info. Visit : http://www.analyzefuture.com/age-related-memory-impairment-pipeline-review-h2-2014-market Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

3. Report Description Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. To Enquire About Report @ http://www.analyzefuture.com/age-related-memory-impairment-pipeline-review-h2-2014-market/report-enquiry The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

4. Scope- The report provides a snapshot of the global therapeutic landscape of Age Related Memory Impairment - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Age Related Memory Impairment and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Age Related Memory Impairment products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects

5. Table of Content Table Of ContentsTable of ContentsTable of Contents 2List of Tables 3List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Age Related Memory Impairment Overview 6Therapeutics Development 7Pipeline Products for Age Related Memory Impairment - Overview 7Pipeline Products for Age Related Memory Impairment - Comparative Analysis 8Age Related Memory Impairment - Therapeutics under Development by Companies 9Age Related Memory Impairment - Pipeline Products Glance 10Clinical Stage Products 10Early Stage Products 11Age Related Memory Impairment - Products under Development by Companies 12Age Related Memory Impairment - Companies Involved in Therapeutics Development 13

6. Table of Content Calico LLC 13Dart NeuroScience LLC 14Pharnext SAS 15Age Related Memory Impairment - Therapeutics Assessment 16Assessment by Monotherapy Products 16Assessment by Target 17Assessment by Mechanism of Action 19Assessment by Route of Administration 21Assessment by Molecule Type 22Drug Profiles 24HT-0712 - Drug Profile 24Product Description 24Mechanism of Action 24R&D Progress 24P7-C3A20 - Drug Profile 25Product Description 25Mechanism of Action 25R&D Progress 25

7. Table of Content PXT-864 - Drug Profile 27Product Description 27Mechanism of Action 27R&D Progress 27rhTFAM for Sepsis and Cognitive Disorders - Drug Profile 28Product Description 28Mechanism of Action 28R&D Progress 28Small Molecules to Activate NAMPT for Neurological Disorders - Drug Profile 30Product Description 30Mechanism of Action 30R&D Progress 30Age Related Memory Impairment - Recent Pipeline Updates 31Age Related Memory Impairment - Dormant Projects 32Appendix 33Methodology 33Coverage 33Secondary Research 33Primary Research 33Expert Panel Validation 33

8. Table of Content Contact Us 34Disclaimer 34List Of TablesList of TablesNumber of Products under Development for Age Related Memory Impairment, H2 2014 7Number of Products under Development for Age Related Memory Impairment - Comparative Analysis, H2 2014 8Number of Products under Development by Companies, H2 2014 9Comparative Analysis by Clinical Stage Development, H2 2014 10Comparative Analysis by Early Stage Development, H2 2014 11Products under Development by Companies, H2 2014 12Age Related Memory Impairment - Pipeline by Calico LLC, H2 2014 13Age Related Memory Impairment - Pipeline by Dart NeuroScience LLC, H2 2014 14Age Related Memory Impairment - Pipeline by Pharnext SAS, H2 2014 15 To Get Complete TOC Visit at: http://www.analyzefuture.com/age-related-memory-impairment-pipeline-review-h2-2014-market/table-of-contents

9. FOR MORE DETAILS Visit us at : http://www.analyzefuture.com/ Stay With Us: 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States. TELEPHONE: +1 (855) 711-1555 EMAIL: sales@analyzefuture.com